Skip to main content

Table 1 Basic information and laboratory findings of CAE patients and normal controls

From: Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups

Groups

NC group (n = 73)

CAE-A (n = 60) (age ≤ 50 years)

CAE-B (n = 83) (50 years<age ≤ 70 years)

CAE-C (n = 74) (age > 70 years)

Total CAE (A + B + C, n = 217)

p-value

CAE-A vs CAE-B

CAE-B vs CAE-C

CAE-A vs CAE-C

Sex (M), n (%)

42 (57.5)

39 (65.0)

57 (68.7)

50 (67.6)

146 (67.3)

0.2794

   

Diabetes mellitus, n (%)

13 (17.8)

11 (18.3)

18 (21.6)

18 (24.3)

47 (21.7)

0.1712

   

Hypertension, n (%)

23 (31.5)

19 (31.7)

28 (33.7)

27 (36.5)

74 (34.1)

0.2142

   

Waist circumference (cm)

90.3 ± 14.8

91.6 ± 12.7

92.7 ± 16.1

93.8 ± 19.1

92.8 ± 16.2

0.5277

   

Creatinine (mg/dL)

70.34 ± 11.6

67.6 ± 12.7

77.8 ± 13.2

87.8 ± 14.8

78.48 ± 12.5

0.2560

   

Smoking index

119.2 ± 15.5

110.3 ± 10.5

135.5 ± 15.6

130.2 ± 15.1

126.7 ± 17.8

0.2391

   

Total cholesterol (mmol/L)

4.89 ± 1.04

5.59 ± 1.21*

5.39 ± 1.18

4.95 ± 1.07

5.30 ± 1.16*

0.0452

0.321

0.252

0.175

Low-density lipoprotein-C (mmol/L)

2.89 ± 0.36

3.92 ± 0.54*

3.74 ± 0.51*

3.73 ± 0.49*

3.79 ± 0.52*

0.0237

0.434

0.523

0.259

High-density lipoprotein-C (mmol/L)

1.08 ± 0.12

1.22 ± 0.27

1.15 ± 0.19

1.13 ± 0.15

1.16 ± 0.16

0.9161

   

Triglycerides (mmol/L)

1.56 ± 0.19

1.69 ± 0.19

1.89 ± 0.21

1.75 ± 0.18

1.78 ± 0.15

0.8493

   

High-sensitivity CRP (mg/L)

16.9 ± 3.82

32.3 ± 5.51*

26.1 ± 4.23*

22.5 ± 4.82*

25.6 ± 4.65*

0.0213

0.230

0.198

0.048*

Glycated hemoglobin (%)

5.89 ± 1.12

5.90 ± 1.07

6.50 ± 1.12

6.89 ± 1.25

6.46 ± 1.21

0.1421

   

Ejection fraction (%)

56.3 ± 12.58

59.4 ± 9.14

55.5 ± 9.23

50.3 ± 8.47

54.8 ± 8.53

0.3432

   

Hemoglobin (g/L)

125.5 ± 26.5

131.1 ± 28.6

125.1 ± 26.3

119.1 ± 29.8

123.8 ± 28.1

0.6535

   

Red blood cell distribution width (%)

36.8 ± 5.26

36.7 ± 5.95

38.7 ± 4.94

36.4 ± 4.68

37.4 ± 5.59

0.8601

   

Mean platelet volume (fL)

10.5 ± 1.26

10.7 ± 1.05

11.2 ± 1.35

10.5 ± 1.91

10.8 ± 1.45

0.2503

   

WBC (109/L)

6.25 ± 2.56

8.85 ± 2.21

8.35 ± 2.06

8.25 ± 2.36

8.38 ± 2.30

0.0763

   

Neutrophils (109/L)

4.12 ± 1.69

6.12 ± 1.58

5.76 ± 1.49

5.66 ± 1.52

5.89 ± 1.60

0.0752

   

Lymphocytes (109/L)

0.50 ± 0.22

0.65 ± 0.25

0.68 ± 0.23

0.72 ± 0.20

0.70 ± 0.23

0.3854

   

Neutrophils/Lymphocytes ratio

8.18 ± 5.36

9.42 ± 6.89

8.48 ± 6.56

7.87 ± 6.36

8.41 ± 6.60

0.1025

   

Interleukin-6 (pg/dL)

4.1 ± 0.6

12.3 ± 1.5*

10.9 ± 1.3*

8.9 ± 1.1*

10.6 ± 1.3*

0.001

0.120

0.095

0.025*

  1. *:NC group vs. Total CAE group. p-value is considered significant if < 0.05